secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envista Holdings Corp (NVST)
CIK:        0001757073
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001757073-24-000063
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envista appoints Eric Hammes as CFO, Stefan Nilsson and Veronica Acurio to lead Nobel Biocare and Ormco
--------------------------------------------------------------------------------

- Eric Hammes appointed CFO effective August 8, 2024; interim CFO Stephen Keller returns to lead investor relations.
- Hammes compensation: base salary $575k, target bonus 75% of salary, LTI $1.2M, one-time cash $1.02M, RSUs $1.2M.
- Stefan Nilsson named President of Nobel Biocare, effective July 15; previously CEO of Colosseum Dental Group.
- Veronica Acurio named President of Orthodontics (Ormco), effective August 2; formerly President of 3M Medical Solutions Division.
- CEO Paul Keel cites relevant dental and healthcare experience; appointments expand leadership team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757073/000175707324000063/0001757073-24-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757073/000175707324000063/nvst-20240715.htm
  HTML page:      https://secwatch.observer/filing/0001757073-24-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer